Antiangiogenic and antitumour effects in vivo of genistein applied alone or combined with cyclophosphamide

Anticancer Research

Volumn 21, Issue 6 A, 2001, Pages 3893-3896

  Wietrzyk, Joanna ^a   Boratynski, Janusz ^a   Grynkiewicz, Grzegorz ^a   Ryczynski, Adam ^a   Radzikowski, Czeslaw ^a   Opolski, Adam ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Angiogenesis quantification; Antiangiogenic treatment; B16 melanoma; Combined antitumour treatment; Cyclophosphamide; Genistein; Lewis lung carcinoma; Mouse tumour models; Tumour angiogenesis

Indexed keywords

ALGINIC ACID; CYCLOPHOSPHAMIDE; GENISTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOSTASIS; LEWIS CARCINOMA; MALE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL CULTURE; TUMOR MODEL; TUMOR VASCULARIZATION; TUMOR VOLUME;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, LEWIS LUNG; CELL DIVISION; CYCLOHEXANES; CYCLOPHOSPHAMIDE; FEMALE; GENISTEIN; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; NEOVASCULARIZATION, PATHOLOGIC; SESQUITERPENES;

EID: 0035570343     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Angiogenesis as a target for tumor treatment
2. Tumor-associated angiogenesis: Mechanisms, clinical implications, and therapeutic strategies
3. Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB, 435 cells
4. Determination of the levels of isoflavonoids in soybeans and soy-derived foods and estimation of isoflavonoids in the Japanese daily intake
5. Soy intake and cancer risk: A review of the in vitro and in vivo data
6. Genistein's "ER-dependent and independent" actions are mediated through ER pathways in ER-positive breast carcinoma cell lines
7. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis
8. Genistein, a specific inhibitor of tyrosine-specific protein kinases
9. Genistein as an inducer of tumor cell differentiation: Possible mechanisms of action
10. Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein
11. Effect of genistein on in vitro and in vivo models of cancer
12. Genistein inhibits growth of B16 melanoma cells in vivo and in vitro and promotes differentiation in vitro
13. Effect of isoflavones genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells
14. Synergistic action of tiazofurin and genistein in human ovarian carcinoma cells
15. Genistein, dietary-derived inhibitor of in vitro angiogenesis
16. The inhibitory, effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro angiogenesis
17. Phytoestrogens and inhibition of angiogenesis
18. A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells
19. A quantitative in vivo mouse model used to assay inhibitors of tumor-induced angiogenesis
20. Assays for angiogenesis: A review
21. Basement membrane biosynthesis as a biochemical index of angiogenesis in chick chorioallantoic membrane
22. The rat and rabbit cornea assays
23. Inhibition of angiogenesis as a mechanism for inhibition by 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rats
24. Antitumor effect of angiogenesis inhibitor 0-(chloroacetyl-carbamoyl) fumagillol (TNP-470) against murine renal cell carcinoma
25. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
26. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis Lung Carcinoma
27. Angiostatin induces and sustains dormancy of human primary tumors in mice
28. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors